In a complex and ever-evolving landscape—with shifting regulatory pressures and stakeholder expectations—biotech and pharma companies must continue prioritizing transparency to build trust, maintain accountability, and drive progress. This panel will bring together industry leaders to share their experiences crafting sustainability strategies, targets, reports, and communications that demonstrate their impact and drive long-term value and resilience. Panelists will explore how companies can align with growing regulations and expectations, while minimizing risk—balancing ambition with authenticity.